Prolonged clinical response to trabectedin in a heavily pretreated patient with advanced uterine leiomyosarcoma: A case report and literature review

被引：5

作者：

Corrado, Giacomo ^{[1
]}

Salutari, Vanda ^{[1
]}

Fuoco, Gilda ^{[1
]}

Lucidi, Alessandro ^{[1
]}

Ferrandina, Gabriella ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Gynecol Oncol Unit, I-86100 Campobasso, Italy

来源：

GYNECOLOGIC ONCOLOGY | 2011年 / 121卷 / 02期

关键词：

Trabectedin; Metastatic uterine leiomyosarcomas; Palliative chemotherapy;

D O I：

10.1016/j.ygyno.2011.01.028

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：416 / 417

页数：2

共 3 条

[1] Clinical Outcome of ET-743 (Trabectedin; Yondelis) in High-Grade Uterine Sarcomas Report on Five Patients and a Review of the Literature [J].

Amant, Frederic ;

Coosemans, An ;

Renard, Vincent ;

Everaert, Els ;

Vergote, Ignace .

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (02) :245-248

[2]

GROSSO F, 2009, J CLIN ONCOL S15S, V27

[3] Phase I and pharmacokinetic study of Yondelis™ (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours [J].

Twelves, C ;

Hoekman, K ;

Bowman, A ;

Vermorken, JB ;

Anthoney, A ;

Smyth, J ;

van Kesteren, C ;

Beijnen, JH ;

Uiters, J ;

Wanders, J ;

Gomez, J ;

Guzmán, C ;

Jimeno, J ;

Hanauske, A .

EUROPEAN JOURNAL OF CANCER, 2003, 39 (13) :1842-1851

← 1 →